You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.
keywords > Therapeutics > Drug Therapy
Patent-sharing scheme for neglected diseases may have catch.
Patent-sharing scheme for neglected diseases may have catch.
Inhibition of proteasome deubiquitinating activity as a new cancer therapy.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
New HCV drugs trigger race for more tolerable therapies.
Four-in-one HIV pill may be exception among combination drugs.
Class of once-weekly diabetes drugs poised for approval.
Patent-sharing scheme for neglected diseases may have catch.
Inhibition of proteasome deubiquitinating activity as a new cancer therapy.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
New HCV drugs trigger race for more tolerable therapies.
Four-in-one HIV pill may be exception among combination drugs.
Class of once-weekly diabetes drugs poised for approval.
Patent-sharing scheme for neglected diseases may have catch.
Inhibition of proteasome deubiquitinating activity as a new cancer therapy.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
New HCV drugs trigger race for more tolerable therapies.
Four-in-one HIV pill may be exception among combination drugs.
Class of once-weekly diabetes drugs poised for approval.
Patent-sharing scheme for neglected diseases may have catch.